Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 95.64% is 32% below its 5-year average of 140.36%, around the middle of its 5-year range (-239.24%–761.17%).
As of the fiscal period ended Saturday, July 4, 2026. 64.62% below its 12-month average of 270.37%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-07-04): 95.64%.
RETURN ON EQUITY (ROE)
95.64%
RETURN ON EQUITY (ROE) AVG TTM
270.37%
RETURN ON EQUITY (ROE) AVG 3Y
270.37%
RETURN ON EQUITY (ROE) AVG 5Y
140.36%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-64.62%
CURRENT VS 3Y AVG
-64.62%
CURRENT VS 5Y AVG
-31.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.54%
median of 579 covered companies
CURRENT VS SECTOR MEDIAN
+341.89%
vs the sector median at left
Aveanna Healthcare Holdings Inc.
Market Cap
$2.69B
Return on Equity (ROE)
95.64%
TTM Avg
270.37%
3Y Avg
270.37%
5Y Avg
140.36%
Market Cap
$2.69B
Return on Equity (ROE)
-0.38%
TTM Avg
-26.55%
3Y Avg
-13.53%
5Y Avg
-6.91%
Market Cap
$2.64B
Return on Equity (ROE)
-8.00%
TTM Avg
-28.91%
3Y Avg
-27.68%
5Y Avg
-39.13%
Market Cap
$2.71B
Return on Equity (ROE)
-56.91%
TTM Avg
-24.13%
3Y Avg
-9.83%
5Y Avg
-11.19%
Market Cap
$2.72B
Return on Equity (ROE)
-25.47%
TTM Avg
-23.80%
3Y Avg
14.67%
5Y Avg
14.67%
Market Cap
$2.74B
Return on Equity (ROE)
-361.91%
TTM Avg
-763.19%
3Y Avg
-396.22%
5Y Avg
-320.76%
Market Cap
$2.63B
Return on Equity (ROE)
-41.10%
TTM Avg
-30.86%
3Y Avg
-32.08%
5Y Avg
-34.60%
Market Cap
$2.78B
Return on Equity (ROE)
2.04%
TTM Avg
-6.01%
3Y Avg
-7.18%
5Y Avg
-5.00%
Market Cap
$2.81B
Return on Equity (ROE)
29.28%
TTM Avg
27.86%
3Y Avg
4.54%
5Y Avg
-12.45%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aveanna Healthcare Holdings Inc. (AVAH) | $2.69B | 95.64% | 270.37% | 270.37% | 140.36% |
| Neogen Corporation (NEOG)vs › | $2.69B | -0.38% | -26.55% | -13.53% | -6.91% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.64B | -8.00% | -28.91% | -27.68% | -39.13% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.71B | -56.91% | -24.13% | -9.83% | -11.19% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.72B | -25.47% | -23.80% | 14.67% | 14.67% |
| Precigen, Inc. (PGEN)vs › | $2.74B | -361.91% | -763.19% | -396.22% | -320.76% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.63B | -41.10% | -30.86% | -32.08% | -34.60% |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 2.04% | -6.01% | -7.18% | -5.00% |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 29.28% | 27.86% | 4.54% | -12.45% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | -73.97% | -48.15% | -105.34% | -79.84% |
ROE
95.6%
ROA
13.0%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-04 | 95.64% |
| 2026-04-04 | 108.93% |
| 2026-01-03 | 115.72% |
| 2025-09-27 | 761.17% |
| 2022-10-01 | -239.24% |
| 2021-10-02 | -0.08% |
| 2021-07-03 | -1.34% |
| 2021-04-03 | -32.48% |
| 2020-12-31 | -21.35% |
